Bank of America’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,468,400
Closed -$66.2M 7422
2025
Q3
$66.2M Buy
1,468,400
+1,258,500
+600% +$58.8M ﹤0.01% 1502
2025
Q2
$9.72M Sell
209,900
-90,500
-30% -$4.44M ﹤0.01% 3250
2025
Q1
$18.3M Sell
300,400
-82,200
-21% -$4.79M ﹤0.01% 2535
2024
Q4
$21.6M Sell
382,600
-5,000
-1% -$279K ﹤0.01% 2230
2024
Q3
$20.1M Sell
387,600
-50,000
-11% -$2.35M ﹤0.01% 2399
2024
Q2
$18.2M Sell
437,600
-424,700
-49% -$19M ﹤0.01% 2352
2024
Q1
$46.8M Buy
862,300
+398,900
+86% +$20.3M ﹤0.01% 1517
2023
Q4
$23.8M Sell
463,400
-33,700
-7% -$1.77M ﹤0.01% 1983
2023
Q3
$28.9M Buy
497,100
+90,700
+22% +$5.56M ﹤0.01% 1694
2023
Q2
$26M Sell
406,400
-260,700
-39% -$17.5M ﹤0.01% 1793
2023
Q1
$46.2M Sell
667,100
-42,000
-6% -$2.96M ﹤0.01% 1423
2022
Q4
$51M Buy
709,100
+148,000
+26% +$11.2M 0.01% 1297
2022
Q3
$39.9M Buy
561,100
+410,400
+272% +$29.8M ﹤0.01% 1421
2022
Q2
$11.6M Sell
150,700
-179,500
-54% -$13.7M ﹤0.01% 2538
2022
Q1
$24.1M Buy
330,200
+234,900
+246% +$15.8M ﹤0.01% 1969
2021
Q4
$5.94M Sell
95,300
-685,100
-88% -$40.2M ﹤0.01% 3472
2021
Q3
$46.2M Buy
780,400
+284,700
+57% +$18.7M ﹤0.01% 1412
2021
Q2
$33.1M Buy
495,700
+86,200
+21% +$5.62M ﹤0.01% 1677
2021
Q1
$25.9M Buy
409,500
+70,600
+21% +$4.39M ﹤0.01% 1814
2020
Q4
$21M Buy
338,900
+259,500
+327% +$16M ﹤0.01% 1842
2020
Q3
$4.79M Sell
79,400
-8,100
-9% -$488K ﹤0.01% 2951
2020
Q2
$5.14M Sell
87,500
-394,900
-82% -$23.6M ﹤0.01% 2805
2020
Q1
$26.9M Sell
482,400
-3,653,500
-88% -$223M ﹤0.01% 1313
2019
Q4
$265M Buy
4,135,900
+2,956,100
+251% +$169M 0.04% 408
2019
Q3
$59.8M Buy
1,179,800
+424,000
+56% +$19.9M 0.01% 1004
2019
Q2
$34.3M Sell
755,800
-959,100
-56% -$44.7M 0.01% 1401
2019
Q1
$81.8M Sell
1,714,900
-201,100
-10% -$10M 0.01% 821
2018
Q4
$99.6M Buy
1,916,000
+157,000
+9% +$8.44M 0.02% 681
2018
Q3
$109M Buy
1,759,000
+1,562,100
+793% +$92.7M 0.02% 686
2018
Q2
$10.9M Sell
196,900
-893,900
-82% -$48.3M ﹤0.01% 2366
2018
Q1
$69M Buy
1,090,800
+243,500
+29% +$15.7M 0.01% 872
2017
Q4
$51.9M Buy
847,300
+270,200
+47% +$16.9M 0.01% 1063
2017
Q3
$36.8M Sell
577,100
-402,300
-41% -$23.5M 0.01% 1388
2017
Q2
$54.6M Sell
979,400
-515,000
-34% -$28M 0.01% 995
2017
Q1
$81.3M Buy
1,494,400
+604,000
+68% +$33.1M 0.02% 779
2016
Q4
$52M Buy
890,400
+403,900
+83% +$22.1M 0.01% 983
2016
Q3
$26.2M Buy
486,500
+4,100
+0.8% +$263K 0.01% 1443
2016
Q2
$35.5M Sell
482,400
-114,900
-19% -$8.12M 0.01% 1196
2016
Q1
$38.2M Buy
597,300
+145,300
+32% +$9.16M 0.01% 1092
2015
Q4
$31.1M Sell
452,000
-362,000
-44% -$23.9M 0.01% 1300
2015
Q3
$48.2M Buy
814,000
+417,100
+105% +$26.5M 0.01% 992
2015
Q2
$26.4M Buy
396,900
+8,600
+2% +$567K 0.01% 1201
2015
Q1
$25M Buy
388,300
+26,300
+7% +$1.65M 0.01% 1202
2014
Q4
$21.4M Sell
362,000
-478,800
-57% -$27M 0.01% 1341
2014
Q3
$43M Buy
840,800
+263,600
+46% +$13.2M 0.01% 921
2014
Q2
$28M Sell
577,200
-480,300
-45% -$23.7M 0.01% 1152
2014
Q1
$54.9M Buy
1,057,500
+454,900
+75% +$24.2M 0.02% 716
2013
Q4
$32M Sell
602,600
-487,100
-45% -$24.8M 0.01% 1003
2013
Q3
$50.4M Buy
1,089,700
+123,700
+13% +$5.43M 0.02% 723
2013
Q2
$43.2M Buy
+966,000
New +$41.9M 0.02% 767

Other funds holding BMY

Bank of America's BMY Position: Q1 2026 in Review

Bank of America increased its Bristol-Myers Squibb (BMY) stake by 116% in Q1 2026, buying an estimated $1.02B and bringing the position to 32,586,981 shares worth $1.98B. The position accounts for 0.14% of the portfolio, ranked #152.

Bank of America first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.59B in Q2 2022. 2,529 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Bank of America held 32,586,981 shares of Bristol-Myers Squibb worth $1.98B as of Q1 2026.
  • Bank of America bought 17,527,686 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.02B.
  • Bristol-Myers Squibb made up 0.14% of Bank of America's portfolio in Q1 2026, its #152 holding.
  • Bank of America first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Bristol-Myers Squibb position peaked at $3.59B in Q2 2022.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.